PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine
Daniel L, Nepal P, Zanussi J, Dickson A, Straub P, Miller‐Fleming T, Wei W, Hung A, Cox N, Kawai V, Mosley J, Stein C, Feng Q, Liu G, Tao R, Chung C. PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine. Clinical And Translational Science 2025, 18: e70220. PMID: 40442974, PMCID: PMC12122386, DOI: 10.1111/cts.70220.Peer-Reviewed Original ResearchConceptsGenome-wide association studiesGenome-wide significancePrincipal components of ancestryImmune cell developmentGenetic risk factorsDose-dependent side effectsAssociation studiesGenetic dataSide effects of azathioprineIntronic variantsElectronic health recordsVanderbilt's electronic health recordEffect of azathioprineCell developmentPTPN2Replication cohortTPMTHealth recordsNUDT15NIH-funded projectDrug discontinuationThiopurine useBioVUXanthine oxidase inhibitorLeukopenia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply